Patients consume one serving of lower dose apigenin celery-banana bread daily on days 1-7, and then consume one serving of higher dose apigenin celery-banana bread on days 8-14. Patients undergo blood sample collection on day 1 prior to and 6 hours after bread ingestion, on day 8 prior to and 6 hours after ingestion of bread, and on day 15 (or endpoint). Patients also provide a baseline urine sample and then 24-hour urine samples on days 1, 7, 8, and 14.

Health Status Unknown

Patients undergo collection of blood and urine

Bio specimen Collection

Dietary Intervention

Laboratory Biomarker Analysis

Ohio State University Comprehensive Cancer Center

Apigenin in Increasing Health Benefits in High Risk Breast Clinic Patients

Celery-Based Dietary Intervention: A Feasibility Study

Paired t-tests will be used to compare mean apigenin levels.

Sagar Sardesai

Principal Investigator

The investigators plan to have approximately 16 persons participate in the study of transimmunization. Transimmunization uses a device, called a UVAR-XTS instrument, to remove a portion of blood, part of which is returned, and part of which is incubated overnight before being returned to the bloodstream the next day

Non-Small Cell Lung Cancer

The photopheresis apparatus and procedure will be identical to that currently used. Patients will receive intravenous 8-MOP (UVADEX®) directly into the photopheresis apparatus, to yield a concentration of 50-200 ng/ml of drug. The blood will be leukapheresed to obtain a buffy coat and will then be passed through the contiguous closed circuit ultraviolet A exposure device, delivering the desired 1-2 joules/cm2 of ultraviolet A energy. In this manner 2-4 molecules of 8-MOP will be induced to bind covalently to thymines of the leukocyte DNA. At that point, the single variation from the standard treatment will be initiated. Instead of returning the patient's cells and the saline to the patient, the bag will be detached from the apparatus. KLH (depyrogenated, endotoxin-free; Calbiochem-Novabiochem Corp., San Diego, CA) will be added at a concentration of 10 g/ml to the DC-rich leukocyte culture prior to overnight culture.

Extracorporeal Photochemotherapy With Transimmunization

Morristown Memorial Hospital

Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer

Phase 1 Toxicity/Feasibility Study: Combined Modality Treatment With Transimmunization for Non-Small Cell Lung Cancer

Atlantic Health System

Chronic Hepatitis C

Chronic Hepatitis B

4-Methylumbelliferone (Heparvit®)

University Health Center Downtown "Brady/Green", 527 North Leona,

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

Evaluation of 4-Methylumbelliferone for Treatment of Chronic Hepatitis B (HBV) and Chronic Hepatitis C (HCV)

horstrissea dolinicola/kanker

Apigenin in Increasing Health Benefits in High Risk Breast Clinic Patients

Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer

4-Methylumbelliferone as a Treatment for Chronic HBV/HCV

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap